Thanks for the detailed reply, Buddyboy20! I didn't know Cytodyn was able to "reconstruct their trial information, by researching the HIV trial site information." That is great news, I thought Amarex held all the cards.
In retrospect, Nadar must have been in a very difficult spot before he went public with the revelations on the failures of our CRO. The shareholders were screaming for BLA submission, but Amarex, apparently, always had enough plausible excuses/lies to keep stringing NP and the board along.
I'm sure NP didn't want to believe that a CRO could so thoroughly obfuscate and botch things up that it would, in retrospect, look deliberate.
To debtors prison for Amarex,
Onward CYDY!!!!!!!!